Literature DB >> 36123447

Radioembolization: Same Player Shoots Again.

Thierry de Baere1,2,3, Laura Crocetti4.   

Abstract

Entities:  

Year:  2022        PMID： 36123447     DOI： 10.1007/s00270-022-03269-x

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN： 0174-1551            Impact factor:   2.797


× No keyword cloud information.
  7 in total

1.  SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer.

Authors:  Guy A van Hazel; Volker Heinemann; Navesh K Sharma; Michael P N Findlay; Jens Ricke; Marc Peeters; David Perez; Bridget A Robinson; Andrew H Strickland; Tom Ferguson; Javier Rodríguez; Hendrik Kröning; Ido Wolf; Vinod Ganju; Euan Walpole; Eveline Boucher; Thomas Tichler; Einat Shacham-Shmueli; Alex Powell; Paul Eliadis; Richard Isaacs; David Price; Fred Moeslein; Julien Taieb; Geoff Bower; Val Gebski; Mark Van Buskirk; David N Cade; Kenneth Thurston; Peter Gibbs
Journal:  J Clin Oncol       Date:  2016-02-22       Impact factor: 44.544

2.  Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial.

Authors:  Etienne Garin; Lambros Tselikas; Boris Guiu; Julia Chalaye; Julien Edeline; Thierry de Baere; Eric Assenat; Vania Tacher; Corentin Robert; Marie Terroir-Cassou-Mounat; Denis Mariano-Goulart; Giuliana Amaddeo; Xavier Palard; Antoine Hollebecque; Marilyne Kafrouni; Hélène Regnault; Karim Boudjema; Serena Grimaldi; Marjolaine Fourcade; Hicham Kobeiter; Eric Vibert; Samuel Le Sourd; Lauranne Piron; Danièle Sommacale; Sophie Laffont; Boris Campillo-Gimenez; Yan Rolland
Journal:  Lancet Gastroenterol Hepatol       Date:  2020-11-06

3.  SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma.

Authors:  Pierce K H Chow; Mihir Gandhi; Say-Beng Tan; Maung Win Khin; Ariunaa Khasbazar; Janus Ong; Su Pin Choo; Peng Chung Cheow; Chanisa Chotipanich; Kieron Lim; Laurentius A Lesmana; Tjakra W Manuaba; Boon Koon Yoong; Aloysius Raj; Chiong Soon Law; Ian H Y Cua; Rolley R Lobo; Catherine S C Teh; Yun Hwan Kim; Yun Won Jong; Ho-Seong Han; Si-Hyun Bae; Hyun-Ki Yoon; Rheun-Chuan Lee; Chien-Fu Hung; Cheng-Yuan Peng; Po-Chin Liang; Adam Bartlett; Kenneth Y Y Kok; Choon-Hua Thng; Albert Su-Chong Low; Anthony S W Goh; Kiang Hiong Tay; Richard H G Lo; Brian K P Goh; David C E Ng; Ganesh Lekurwale; Wei Ming Liew; Val Gebski; Kenneth S W Mak; Khee Chee Soo
Journal:  J Clin Oncol       Date:  2018-03-02       Impact factor: 44.544

Review 4.  BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update.

Authors:  Maria Reig; Alejandro Forner; Jordi Rimola; Joana Ferrer-Fàbrega; Marta Burrel; Ángeles Garcia-Criado; Robin K Kelley; Peter R Galle; Vincenzo Mazzaferro; Riad Salem; Bruno Sangro; Amit G Singal; Arndt Vogel; Josep Fuster; Carmen Ayuso; Jordi Bruix
Journal:  J Hepatol       Date:  2021-11-19       Impact factor: 30.083

5.  Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial.

Authors:  Valérie Vilgrain; Helena Pereira; Eric Assenat; Boris Guiu; Alina Diana Ilonca; Georges-Philippe Pageaux; Annie Sibert; Mohamed Bouattour; Rachida Lebtahi; Wassim Allaham; Hélène Barraud; Valérie Laurent; Elodie Mathias; Jean-Pierre Bronowicki; Jean-Pierre Tasu; Rémy Perdrisot; Christine Silvain; René Gerolami; Olivier Mundler; Jean-Francois Seitz; Vincent Vidal; Christophe Aubé; Frédéric Oberti; Olivier Couturier; Isabelle Brenot-Rossi; Jean-Luc Raoul; Anthony Sarran; Charlotte Costentin; Emmanuel Itti; Alain Luciani; René Adam; Maïté Lewin; Didier Samuel; Maxime Ronot; Aurelia Dinut; Laurent Castera; Gilles Chatellier
Journal:  Lancet Oncol       Date:  2017-10-26       Impact factor: 41.316

6.  First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials.

Authors:  Harpreet S Wasan; Peter Gibbs; Navesh K Sharma; Julien Taieb; Volker Heinemann; Jens Ricke; Marc Peeters; Michael Findlay; Andrew Weaver; Jamie Mills; Charles Wilson; Richard Adams; Anne Francis; Joanna Moschandreas; Pradeep S Virdee; Peter Dutton; Sharon Love; Val Gebski; Alastair Gray; Guy van Hazel; Ricky A Sharma
Journal:  Lancet Oncol       Date:  2017-08-03       Impact factor: 41.316

7.  Yttrium-90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study.

Authors:  Riad Salem; Guy E Johnson; Edward Kim; Ahsun Riaz; Vivian Bishay; Eveline Boucher; Kirk Fowers; Robert Lewandowski; Siddharth A Padia
Journal:  Hepatology       Date:  2021-06-11       Impact factor: 17.425
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.